Enhanced degradation of cathepsin D synthesized in the presence of the threonine analog beta-hydroxynorvaline.
about
Molecular characterisation of 'transmembrane protein 192' (TMEM192), a novel protein of the lysosomal membraneCathepsin D--many functions of one aspartic proteaseTwo dileucine motifs mediate late endosomal/lysosomal targeting of transmembrane protein 192 (TMEM192) and a C-terminal cysteine residue is responsible for disulfide bond formation in TMEM192 homodimers.Disrupted in renal carcinoma 2 (DIRC2), a novel transporter of the lysosomal membrane, is proteolytically processed by cathepsin L.Heterogeneity in late-onset metachromatic leukodystrophy. Effect of inhibitors of cysteine proteinases.Inhibition of early but not late proteolytic processing events leads to the missorting and oversecretion of precursor forms of lysosomal enzymes in Dictyostelium discoideum.Processing of human cathepsin D is independent of its catalytic function and auto-activation: involvement of cathepsins L and B.Procathepsin D and cancer: From molecular biology to clinical applications.Intracellular protein catabolism: state of the art.A replacement of the active-site aspartic acid residue 293 in mouse cathepsin D affects its intracellular stability, processing and transport in HEK-293 cells.The half-life of human procathepsin S.Biosynthesis of secreted beta-hexosaminidase in Tetrahymena thermophila. A comparison of the wild type with a secretory mutantProteolytic processing of porcine deoxyribonuclease II occurs in lysosomes but is not required for enzyme activation.Effects of cysteine protease inhibitors on rabbit cathepsin D maturation.Differential segregation of human and hamster cathepsin D in transfected baby-hamster kidney cellsExpression and maturation of human cathepsin D in baby-hamster kidney cells.Changes induced in astrocyte cathepsin D by cytokines and leupeptin.
P2860
Q24305928-90E04A96-A857-48B1-94EF-AF772706CF55Q28275626-950D9090-BB6A-4AB0-9F54-443A6ED0DA8CQ34153945-C39BDBA1-607D-4BB1-AD50-973C25C45758Q34194342-C176D089-FCC8-456E-BCDA-303A466944DFQ35198709-6EA5E9D7-0D1E-4804-840D-70450B36770DQ36221156-8528B796-6FD9-4AC2-98C7-22CBEC3181A4Q36646524-F7E17F97-9759-4191-BEC2-0AE996551E42Q37878301-15838407-8290-441F-8E6F-AA1850BFA3ECQ39500408-204A36D3-763A-4DAC-805B-3065530C8F36Q40701217-9946D160-C175-449A-8FCA-4B1DC6002E5AQ40932134-33D49559-996D-4989-8067-97E36C046B93Q41879066-5B2D5035-A81D-482A-B1B2-37C3225241DDQ41938889-FD3294DF-CEF0-4707-8329-B4A81C7AB8E6Q41945044-17738561-849A-407D-B0ED-E11790418F25Q42135891-CFF28847-9D2C-4EBF-958C-673890C5597CQ42174505-584D3433-C7BC-40D9-B9E9-BE64DEFC50D2Q48679559-D6E99DE4-F197-49F3-8349-EC9669197BA4
P2860
Enhanced degradation of cathepsin D synthesized in the presence of the threonine analog beta-hydroxynorvaline.
description
1984 nî lūn-bûn
@nan
1984 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1984 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
name
Enhanced degradation of cathep ...... analog beta-hydroxynorvaline.
@ast
Enhanced degradation of cathep ...... analog beta-hydroxynorvaline.
@en
Enhanced degradation of cathep ...... analog beta-hydroxynorvaline.
@nl
type
label
Enhanced degradation of cathep ...... analog beta-hydroxynorvaline.
@ast
Enhanced degradation of cathep ...... analog beta-hydroxynorvaline.
@en
Enhanced degradation of cathep ...... analog beta-hydroxynorvaline.
@nl
prefLabel
Enhanced degradation of cathep ...... analog beta-hydroxynorvaline.
@ast
Enhanced degradation of cathep ...... analog beta-hydroxynorvaline.
@en
Enhanced degradation of cathep ...... analog beta-hydroxynorvaline.
@nl
P1476
Enhanced degradation of cathep ...... analog beta-hydroxynorvaline.
@en
P2093
von Figura K
P304
P356
10.1016/0003-9861(84)90120-6
P407
P577
1984-04-01T00:00:00Z